Cancer Cells Mimic White Blood Cells to Metastasize: NHRI Deciphers Target-Driving Protein
NQ Score
74/100
AI Summary (NQ-processed)
A National Health Research Institutes (NHRI) team discovered that cancer cells mimic white blood cells, moving like amoebas to enter and exit blood vessels and metastasize to distant tissues. This process is driven by the overexpression of the transmembrane protein MYADM, which is significantly correlated with high recurrence rates and low patient survival in various cancers. The team has developed preliminary monoclonal antibodies and proteolysis-targeting chimeras (PROTACs), and confirmed that blocking MYADM significantly reduces cancer cell dissemination, offering a new potential target for cancer therapy.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What percentage of cancer patient deaths are caused by cancer cell metastasis?
- A: According to the article, ninety percent of cancer patient deaths are caused by metastasis.
- Q: What did the National Health Research Institutes team discover about how cancer cells metastasize?
- A: They discovered that cancer cells mimic white blood cells, crawling like amoebas to enter and exit blood vessels.
- Q: What protein's overexpression is identified as the key to cancer cells mimicking white blood cells to metastasize?
- A: The key lies in the overexpression of the transmembrane protein known as MYADM.
- Q: What potential tools for cancer treatment has the research team preliminarily developed?
- A: They have preliminarily developed monoclonal antibodies and proteolysis-targeting chimeras (PROTACs).
- Q: How do white blood cells migrate when the body is inflamed, according to Dr. Dai-Lung Cha?
- A: They migrate in an amoeba-like manner, forming spherical protrusions on the cell membrane.